Innovation Solutions

  1. Rescuing Proteins With Scalable Insect Expression 9/29/2026

    Overcome protein expression bottlenecks with a scalable insect-based platform that delivers faster development, predictable scale-up, and consistent manufacturing.

  2. The EntoEngine: Fruit Flies For Advanced Biomanufacturing 9/27/2026

    Produce recombinant proteins at scale with stable expression, flexible batch sizes, and streamlined manufacturing.

  3. Quantum-Enabled EPR For Structural Biology And Drug Discovery 9/24/2026

    Capturing dynamic conformational states is key to target druggability. Advanced EPR spectroscopy delivers nanometer-resolution measurements for complex structural biology.

  4. Designed For Difficult Biology 6/17/2026

    Macrocycles expand drug discovery into previously inaccessible targets. With validated success and flexible approaches, they provide a powerful path for tackling the most challenging biology.

  5. Hybridoma Services 6/5/2026

    Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.

  6. Phage And Yeast Display 6/5/2026

    Curia offers phage and eukaryotic-based yeast display platforms for in vitro discovery and engineering of potent antibody candidates for therapeutic or diagnostic use. High-affinity functional antibodies are routinely selected against a wide range of conventional or challenging targets (e.g. GPCRs) using customized or in-licensed state-of-the-art libraries.

  7. Recombinant Antibody Production 6/5/2026

    Curia has extensive experience with constructing and producing antibodies in our mammalian platforms.

  8. Antibody Developability Analysis 6/5/2026

    Evaluating the developability of therapeutic drug candidates early can help circumvent potential issues in late-stage development.

  9. Small Molecule Discovery Network And Capabilities 6/5/2026

    Our collaborative approach, proven track record, and deep technical expertise enable us to efficiently advance promising candidates, reduce development risk, and help transform innovative ideas into successful therapeutic realities.

  10. Protein Expression And Analysis 5/28/2026

    Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.